Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination (Q45418253)

14 December 2017

Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination (English)

1 reference

14 December 2017

0 references

J M Minke

1

1 reference

14 December 2017

L Fischer

2

1 reference

14 December 2017

Ph Baudu

3

1 reference

14 December 2017

P M Guigal

4

1 reference

14 December 2017

T Sindle

5

1 reference

14 December 2017

J A Mumford

6

1 reference

14 December 2017

J C Audonnet

7

1 reference

14 December 2017

31 March 2006

1 reference

Veterinary Immunology and Immunopathology

14 December 2017

1 reference

14 December 2017

111

1 reference

14 December 2017

1-2

1 reference

14 December 2017

47-57

1 reference

A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Rabies DNA vaccine in the horse: strategies to improve serological responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

An improved plasmid DNA expression vector for direct injection into skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Epizootiological Aspects of Type 1 and Type 4 Equine Herpesvirus Infections among Horse Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Equine viral vaccines: the past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Relative potency of cellular and humoral immune responses induced by DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Differentiation of Respiratory and Abortigenic Isolates of Equine Herpesvirus 1 by Restriction Endonucleases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Enhancement of DNA vaccine potency using conventional aluminum adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

Equine herpesvirus 1 and 4 infections: an update.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Serological Detection of Equid Herpesvirus1 Infections of the Respiratory Tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.01.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2006.01.008

1 reference

14 December 2017

1 reference